欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/2394/001
药品名称Medovir
活性成分
    • aciclovir 250.0 mg
剂型Powder for solution for infusion
上市许可持有人Medochemie Iberia, S.A.
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Spain (ES)
    • Greece (GR)
    • Latvia (LV)
      Aciclovir Medochemie 250 mg pulveris infūziju šķīduma pagatavošanai
    • Lithuania (LT)
      ACICLOVIR MEDOCHEMIE 250 mg milteliai infuziniam tirpalui
    • Estonia (EE)
      MEDOVIR
    • Bulgaria (BG)
      Medovir
    • Cyprus (CY)
      Medolone 250mg Powder for solution for infusion
    • Romania (RO)
      Medovir 250 mg Pulbere pentru soluţie perfuzabilă
    • Slovakia (SK)
      MEDOVIR 250 mg prášok na infúzny roztok
    • Malta (MT)
许可日期2020/11/05
最近更新日期2022/05/10
药物ATC编码
    • J05AB01 aciclovir
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase